Home300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Previous close
¥18.50
Day range
¥18.29 - ¥18.62
Year range
¥12.93 - ¥34.18
Market cap
20.42B CNY
Avg Volume
18.87M
P/E ratio
40.58
Dividend yield
2.07%
Primary exchange
SHE
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 816.14M | 11.21% |
Operating expense | 441.56M | 6.14% |
Net income | 185.76M | -0.46% |
Net profit margin | 22.76 | -10.50% |
Earnings per share | 0.16 | -2.13% |
EBITDA | 348.52M | 22.34% |
Effective tax rate | 6.09% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 310.71M | -70.41% |
Total assets | 14.52B | -1.41% |
Total liabilities | 4.81B | -6.59% |
Total equity | 9.71B | — |
Shares outstanding | 1.12B | — |
Price to book | 2.13 | — |
Return on assets | 5.17% | — |
Return on capital | 6.38% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 185.76M | -0.46% |
Cash from operations | 178.68M | -37.64% |
Cash from investing | -262.60M | -774.60% |
Cash from financing | -42.46M | -25,008.80% |
Net change in cash | -126.53M | -149.37% |
Free cash flow | -1.95B | -214.48% |
About
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Founded
Sep 8, 1992
Website
Employees
1,902
